Evolv Technologies Holdings, Inc. (EVLV)
NASDAQIndustrialsSecurity & Protection ServicesSnapshot 2026-09-04
$5.00+0.60%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsSecurity & Protection ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · EVLV
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Other Events. On August 6, 2026, the United States District Court for the District of Massachusetts (the “Court”) preliminarily approved the settlement (“Settlement”) of stockholder derivative claims actually or threatened to be brought on behalf of Evolv Technologies Holdings, Inc. (the “Company” or “Evolv”) in accordance with that certain Stipulation and Agreement of Settlement dated August 5, 2026. The Settlement fully and finally resolves the following stockholder derivative matters with…
of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Forward-Looking Statements This Current Report on Form 8-K contains forward-lo…
of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Director — Bilal Zuberi: Mr. Zuberi resigned to pursue other endeavors, and a successor was appointed.
of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Chief Innovation Officer — Mr. Michael Ellenbogen: Resigned due to new time commitments.
Entry into a Credit Agreement. On July 29, 2025, Evolv Technologies, Inc. (the ” Borrower ”), a direct, wholly-owned subsidiary of Evolv Technologies Holdings, Inc. (“ the Company ”), entered into the Credit, Security and Guaranty Agreement (the “ Credit Agreement ”), by and among the Borrower, the Company, MidCap Financial Trust, as agent and term loan service and the other lenders party thereto, that provides for an initial $30 million term loan facility, $30 million delayed draw facility (…
of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Results of Operations and Financial Condition. On April 28, 2025, Evolv Technologies Holdings, Inc. (the “Company”), in connection with its restatement of certain historical financial statements, filed with the Securities and Exchange Commission its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024 and its Annual Report on Form 10-K for the fiscal year ended December 31, 2024. On April 28, 2025, the Company also announced its financial results for the fiscal quarte…
Chief Financial Officer — George C. Kutsor: The company hired a new CFO with extensive experience.
Regulation FD Disclosure. On April 22, 2025, the Company issued a press release in accordance with Nasdaq Listing Rule 5810(b) announcing that the Company had received the Notice. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 16, 2025, Evolv Technologies Holdings, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Nasdaq Listing Rule”) as a result of the delayed filing of the Company’s Annual Report on Form 10-K for the…
Director and Audit Committee Member — Richard Shapiro: Appointment of Richard Shapiro as a Class II director and to the Audit Committee.
Chief Commercial Officer — Jay Muelhoefer: Jay Muelhoefer will no longer serve as Chief Commercial Officer, with severance benefits contingent on a release of claims.
Results of Operations and Financial Condition. On January 23, 2025, Evolv Technologies Holdings, Inc. (the “Company”) issued a press release providing business updates on select strategic metrics of the Company for the three-month period ended December 31, 2024, the Company’s pending restatement effort and other regulatory matters (the “Press Release”). The full text of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The transcript referenced in
Costs Associated with Exit or Disposal Activities. On January 21, 2025, the Board approved a reduction in force involving 40 employees in all organizations across the Company, representing approximately 14% of the Company’s workforce. This action is part of the Company’s initiative to increase its annualized run rate cash savings as the Company seeks further flexibility to pursue its investment strategy with certain growth opportunities. The Company expects to incur pre-tax charges of approxi…
of this Current Report on Form 8-K (including Exhibits 99.1 and 99.2) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing. Forward-looking Stat…
Director — Merline Saintil: Ms. Saintil resigned from the Board to pursue other endeavors.
Director — Peter George: Peter George resigned from the Board of Directors effective immediately.
President and Chief Executive Officer — John Kedzierski: John Kedzierski was appointed as the new President and Chief Executive Officer of Evolv Technologies Holdings, Inc.
Regulation FD Disclosure. On November 22, 2024, the Company issued a press release in accordance with Nasdaq Listing Rule 5810(b) announcing that the Company had received the Notice. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwi…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 21, 2024, Evolv Technologies Holdings, Inc. (the “Company”) received an expected delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Nasdaq Listing Rule”) as a result of the delayed filing of the Company’s…
of this Current Report on Form 8-K (including Exhibit 99.1), shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as may be expressly set forth by specific reference in such filing. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATE…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.